Lankalapalli RS - Search Results

1

In vitro antibacterial effects of combination of ciprofloxacin with compounds isolated from Streptomyces luteireticuli NIIST-D75.

Jesmina ARS, Induja DK, Drissya T, Sruthi CR, Raghu KG, Nelson-Sathi S, Kumar BNSAD, Lankalapalli RS. Jesmina ARS, et al. Among authors: lankalapalli rs. J Antibiot (Tokyo). 2023 Apr;76(4):198-210. doi: 10.1038/s41429-023-00600-7. Epub 2023 Feb 13. J Antibiot (Tokyo). 2023. PMID: 36781977

2

A novel aureothin diepoxide derivative from Streptomyces sp. NIIST-D31 strain.

Drissya T, Induja DK, Poornima MS, Jesmina ARS, Prabha B, Saumini M, Suresh CH, Raghu KG, Kumar BSD, Lankalapalli RS. Drissya T, et al. Among authors: lankalapalli rs. J Antibiot (Tokyo). 2022 Sep;75(9):491-497. doi: 10.1038/s41429-022-00547-1. Epub 2022 Aug 4. J Antibiot (Tokyo). 2022. PMID: 35922482

3

Isolation of two new stereochemical variants of streptophenazine by cocultivation of Streptomyces NIIST-D31, Streptomyces NIIST-D47, and Streptomyces NIIST-D63 strains in ³C₂ combinations.

Induja DK, Jesmina ARS, Joseph MM, Shamjith S, Ingaladal N, Maiti KK, Kumar BSD, Lankalapalli RS. Induja DK, et al. Among authors: lankalapalli rs. J Antibiot (Tokyo). 2023 Oct;76(10):567-578. doi: 10.1038/s41429-023-00638-7. Epub 2023 Jun 13. J Antibiot (Tokyo). 2023. PMID: 37308605

4

In vitro antibacterial screening of six proline-based cyclic dipeptides in combination with β-lactam antibiotics against medically important bacteria.

Kumar SN, Lankalapalli RS, Kumar BS. Kumar SN, et al. Among authors: lankalapalli rs. Appl Biochem Biotechnol. 2014 May;173(1):116-28. doi: 10.1007/s12010-014-0808-3. Epub 2014 Mar 13. Appl Biochem Biotechnol. 2014. PMID: 24622848

5

Synergistic activity of phenazines isolated from Pseudomonas aeruginosa in combination with azoles against Candida species.

Nishanth Kumar S, Nisha GV, Sudaresan A, Venugopal VV, Sree Kumar MM, Lankalapalli RS, Dileep Kumar BS. Nishanth Kumar S, et al. Among authors: lankalapalli rs. Med Mycol. 2014 Jul;52(5):482-90. doi: 10.1093/mmy/myu012. Epub 2014 Jun 9. Med Mycol. 2014. PMID: 24915852

6

Expedient Synthesis of Indolo[2,3-b]quinolines, Chromeno[2,3-b]indoles, and 3-Alkenyl-oxindoles from 3,3'-Diindolylmethanes and Evaluation of Their Antibiotic Activity against Methicillin-Resistant Staphylococcus aureus.

Challa C, Ravindran J, Konai MM, Varughese S, Jacob J, Kumar BSD, Haldar J, Lankalapalli RS. Challa C, et al. Among authors: lankalapalli rs. ACS Omega. 2017 Aug 31;2(8):5187-5195. doi: 10.1021/acsomega.7b00840. Epub 2017 Aug 30. ACS Omega. 2017. PMID: 30023741 Free PMC article.

7

First report on isolation of 2,3,4-trihydroxy-5-methylacetophenone from palmyra palm (Borassus flabellifer Linn.) syrup, its antioxidant and antimicrobial properties.

Reshma MV, Jacob J, Syamnath VL, Habeeba VP, Dileep Kumar BS, Lankalapalli RS. Reshma MV, et al. Among authors: lankalapalli rs. Food Chem. 2017 Aug 1;228:491-496. doi: 10.1016/j.foodchem.2017.02.043. Epub 2017 Feb 11. Food Chem. 2017. PMID: 28317754

8

Isolation and antifungal properties of cyclo(D-Tyr-L-Leu) diketopiperazine isolated from Bacillus sp. associated with rhabditid entomopathogenic nematode.

Kumar N, Gorantla JN, Mohandas C, Nambisan B, Lankalapalli RS. Kumar N, et al. Among authors: lankalapalli rs. Nat Prod Res. 2013;27(23):2168-72. doi: 10.1080/14786419.2013.796466. Epub 2013 May 14. Nat Prod Res. 2013. PMID: 23672207

9

Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells.

Shilpa G, Lakshmi S, Jamsheena V, Lankalapalli RS, Prakash V, Anbumani S, Priya S. Shilpa G, et al. Among authors: lankalapalli rs. Basic Clin Pharmacol Toxicol. 2022 Oct;131(4):224-240. doi: 10.1111/bcpt.13767. Epub 2022 Jul 8. Basic Clin Pharmacol Toxicol. 2022. PMID: 35750657 Free article.

10

A potent bioactive fraction against colon cancer from Plectranthus vettiveroides.

Athikkavil FM, Aiswarya SU, Johny R, Sudhesh M, Nisthul AA, Lankalapalli RS, Anto RJ, Bava SV. Athikkavil FM, et al. Among authors: lankalapalli rs. Explor Target Antitumor Ther. 2023;4(2):227-239. doi: 10.37349/etat.2023.00131. Epub 2023 Apr 24. Explor Target Antitumor Ther. 2023. PMID: 37205312 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page